Venture capital firm based in London, UK
UKI2S invests in ExactTrak, a trailblazing post-quantum cybersecurity solution provider disrupting the industry with world-first patented technology and strategic partnerships with Dell and the UK Government. Read more
Unlocking the future of quantum sensing, Aquark Technologies secures €5 million in funding, positioning itself as a game-changer in advanced security and defense technology! Read more
Antiverse Ltd is shaking up biotechnology with the discovery of eight powerful antibody clusters and a $3 million investment, paving the way for groundbreaking therapies targeting human GPCRs! Read more
Machine Discovery, a UK and US-based software company, secures £4.5M in funding to fuel the commercial adoption of its machine learning technology, which aims to expedite compute-intensive tasks in the semiconductor design space and other markets. Read more
Sention Technologies secures £3.7 million to enhance battery diagnostics with its innovative ultrasound tech—paving the way for smarter energy solutions! Read more
Glasgow's Solasta Bio secures $14 million in Series A funding to revolutionize sustainable agriculture with its nature-inspired bioinsecticides, ensuring a healthier ecosystem while effectively combating pests! Read more
London-based company NK:IO secures £1.2M in funding to advance its groundbreaking cell therapy technology, targeting solid tumors and revolutionizing cancer treatment, with a focus on ovarian cancer and collaboration with esteemed expert, Prof. Iain McNeish. Read more
Wave Photonics secures £4.5M to revolutionize on-chip photonics design for quantum technologies and datacentre applications, set to accelerate the adoption of next-generation integrated photonics products in a wide range of industries. Read more
Biotech | 45.5% |
AI | 27.3% |
Cyber security | 9.1% |
Energy | 9.1% |
Healthtech | 9.1% |